Global framework for biosimilars "is now crucial" – Pharma Times
Global framework for biosimilars "is now crucial"Pharma TimesGiven the upcoming patient expiries on a number of major biologic drugs, including Roche's Herceptin (trastuzumab) and Rituxan (rituximab), Sanofi's Lantus Insulin glargine)…
